SOHO 2023 | Challenges with MDS classification: morphological characterization and molecular testing
Uwe Platzbecker, MD, University of Leipzig, Leipzig, Germany, discusses challenges associated with the morphological characterization of myelodysplastic syndromes (MDS), highlighting issues such as inter-observer variability. Prof. Platzbecker also comments on recent revisions to the World Health Organization (WHO) classification of MDS, and further emphasizes the importance of molecular testing in the assessment of patients with MDS. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Grant support, paid to GWT-TUD, from Amgen; lecture fees and grant support, paid to the University of Leipzig, from Amgen; fees for serving on a steering committee, consulting fees, and travel support from Bristol Myers Squibb; grant support, paid to GWT-TUD, from Janssen Biotech; grant support, paid to University Dresden, from Merck and Novartis; lecture and consulting fees from Novartis; and consulting fees from AbbVie, Curis, and Geron.
